Ipca Laboratories Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
29971.35 Cr.
|
P/BV
|
4.73
|
Book Value (Rs.)
|
249.59
|
52 Week High/Low (Rs.)
|
1375/691
|
FV/ML
|
1/1
|
P/E(X)
|
54.76
|
Bookclosure
|
22/11/2023
|
EPS (Rs.)
|
21.57
|
Div Yield (%)
|
0.34
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 |
No. of Equity Shares (in Lacs) | 2537.00 | 2537.04 | 2537.04 | 1268.52 | 1263.52 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.27 |
Total Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.27 |
| | | | | |
Reserves and Surplus | 6306.82 | 5816.65 | 5466.60 | 4676.28 | 3590.27 |
Total Reserves and Surplus | 6306.82 | 5816.65 | 5466.60 | 4676.28 | 3590.27 |
Money Received Against Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 11.94 |
Total Shareholders Funds | 6332.19 | 5842.02 | 5491.97 | 4701.65 | 3627.48 |
Minority Interest | 1394.81 | 73.30 | 76.92 | 14.53 | 13.63 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 580.41 | 651.78 | 395.18 | 9.13 | 102.97 |
Deferred Tax Liabilities [Net] | 310.47 | 189.16 | 152.58 | 133.55 | 141.82 |
Other Long Term Liabilities | 40.92 | 17.36 | 13.60 | 10.40 | 15.28 |
Long Term Provisions | 86.84 | 46.99 | 42.73 | 38.56 | 32.23 |
Total Non-Current Liabilities | 1018.64 | 905.29 | 604.09 | 191.64 | 292.30 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 807.09 | 805.75 | 396.06 | 243.21 | 310.95 |
Trade Payables | 776.08 | 525.06 | 557.70 | 664.86 | 609.85 |
Other Current Liabilities | 527.91 | 366.98 | 410.60 | 149.33 | 311.92 |
Short Term Provisions | 244.56 | 108.03 | 101.52 | 103.14 | 93.70 |
Total Current Liabilities | 2355.64 | 1805.82 | 1465.88 | 1160.54 | 1326.42 |
| | | | | |
Total Capital And Liabilities | 11101.28 | 8626.43 | 7638.86 | 6068.36 | 5259.83 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 4805.84 | 2572.41 | 2208.75 | 1962.79 | 1922.45 |
Intangible Assets | 0.00 | 140.83 | 154.61 | 63.04 | 73.84 |
Capital Work-In-Progress | 0.00 | 122.17 | 293.85 | 183.66 | 70.80 |
Intangible Assets Under Development | 0.00 | 18.26 | 12.58 | 51.16 | 62.48 |
Fixed Assets | 4805.84 | 2853.67 | 2669.79 | 2260.65 | 2129.57 |
Goodwill On Consolidation | 90.58 | 38.14 | 54.16 | 46.60 | 62.44 |
Non-Current Investments | 303.61 | 302.66 | 269.88 | 111.43 | 71.31 |
Deferred Tax Assets [Net] | 4.23 | 3.57 | 2.02 | 1.95 | 2.01 |
Long Term Loans And Advances | 88.59 | 115.90 | 71.40 | 139.47 | 99.41 |
Other Non-Current Assets | 269.53 | 123.22 | 114.44 | 71.30 | 39.38 |
Total Non-Current Assets | 5562.38 | 3437.16 | 3181.69 | 2631.40 | 2404.12 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 558.40 | 323.32 | 719.31 | 393.83 | 238.25 |
Inventories | 2471.31 | 1743.37 | 1857.97 | 1594.81 | 1323.12 |
Trade Receivables | 1686.51 | 989.02 | 910.78 | 811.75 | 895.20 |
Cash And Cash Equivalents | 296.84 | 1853.24 | 640.66 | 365.07 | 180.92 |
Short Term Loans And Advances | 9.40 | 3.23 | 10.34 | 2.47 | 2.95 |
OtherCurrentAssets | 516.44 | 277.09 | 318.11 | 269.03 | 215.27 |
Total Current Assets | 5538.90 | 5189.27 | 4457.17 | 3436.96 | 2855.71 |
| | | | | |
Total Assets | 11101.28 | 8626.43 | 7638.86 | 6068.36 | 5259.83 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 0.00 | 2125.64 | 274.03 | 369.48 | 198.98 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 0.00 | 10.45 | 10.45 | 20.90 | 20.90 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Unquoted Book Value | 0.00 | 172.85 | 155.19 | 34.17 | 37.65 |
| | | | | |
CURRENT INVESTMENTS | | | | | |
Current Investments Quoted Market Value | 0.00 | 323.32 | 719.31 | 393.83 | 238.25 |